MAP2K7 and cancer: In this study, we reported that in multiple human cancer cell lines, MLN4924 increased PD-L1 expression in dose- and time-dependent manners mainly through the activation of transcription factor AP-1 via MEK signals, leading to the establishment of a cancer-associated immunosuppression environment.